To examine mechanisms whereby the abundance of functional Ca channels may be regulated in excitable tissue, Ca channel number was estimated by binding of the dihydropyridine (DHP) antagonist 3H(+)PN200-110 to monolayers of intact myocytes from chick embryo ventricle. Beta adrenergic receptor properties were studied in cultured myocytes using VH1-CGP12177, an antagonist ligand. Physiological correlates for alterations in DHP binding site number included 45Ca uptake and contractile response to (±)BAYk 8644, a specific L-type Ca channel activator. All binding and physiological determinations were performed in similar intact cell preparations under identical conditions. 4-h exposure to 1 MM isoproterenol reduced cell surface,l8-adrenergic receptor number from 44±3 to 17±2 fmol/mg (P < 0.05); DHP binding sites declined in number from 113±25 to 73±30 fmol/mg (P < 0.03). When protein kinase A was activated by a non-receptor-dependent mechanism, DHP binding declined similarly to 68% of control. Exposure to diltiazem, a Ca channel antagonist, for 18-24 h had no effect on number of DHP binding sites. After 4-h isoproterenol exposure, 45Ca uptake stimulated by BAYk 8644 declined from 3.3±0.2 nmol/mg to 2.9±0.3 nmol/mg (P < 0.01) and BAYk 8644-stimulated increase in amplitude of contraction declined from 168±7 to 134±11% (P = 0.02). Thus, elevation of [cAMP] in myocytes is associated with a time-dependent decline in Ca channel abundance as estimated by DHP binding and a decline in physiological responses that are in part dependent on abundance of Ca channels.
Introduction
Cardiac myocytes contain voltage-sensitive, L-type calcium channels that play a pivotal role in regulation of excitationcontraction coupling. (1, 2) . Calcium channels are known to be present in the sarcolemma, although the exact locus relative to t-tubules and sarcoplasmic reticulum in heart is uncertain. It is not known whether there are also intracellular pools of calcium channels. Among the important gaps in our understanding of the role of calcium channels in control of excita-tion-contraction coupling and excitation-secretion coupling is the limited understanding of factors that determine how many functional calcium channels are present in the sarcolemma. Compared with membranes from skeletal muscle, calcium channels in heart are of low abundance, which has hampered studies on processes that regulate channel expression and function. Previous work from this laboratory has demonstrated that during cardiac ontogeny, the number of calcium channels as determined by dihydropyridine (DHP)' calcium channel antagonist binding increases. In the developing chick heart, these changes in expression of DHP binding sites occur over the course of days (3) . In contrast, for channels present in the sarcolemma at any one moment, gating properties of Ltype channels can be modulated over the course of milliseconds to seconds by membrane potential and by drugs (1, 4) . It is now well established that (3-adrenergic agonist occupancy of the cardiac beta receptor rapidly produces calcium channel phosphorylation and alterations in gating properties through the adenylate cyclase-protein kinase A pathway (5). It is not known whether expression of DHP binding sites and ensemble function of L-type calcium channel in heart can be regulated by tonic exposure to indirect (,B-adrenergic) and direct calcium channel effectors. This study investigates those questions.
Previous work on developing skeletal muscle myotubes demonstrated that over the course of days, alterations in ,Badrenergic stimulation could alter expression of calcium channels (6) . However, the functional role ofcalcium channels in skeletal muscle cells is poorly understood. It is highly likely that < 1 in 1,000 channels actually participate in calcium flux; the majority may serve as voltage transducers (7) . This investigation therefore studied calcium channel regulation in a cardiac model system where the function of Ca channels is more clearly delineated. A cultured chick ventricular myocyte preparation was used that has previously been well characterized with respect to ,B receptor and calcium channel properties (2, (8) (9) (10) . We now report that under some conditions in intact heart cells, expression of cell surface ,B-adrenergic receptors, DHP binding sites, and calcium channel functional properties can be coregulated.
Methods
Tissue culture. Primary monolayer cultures of spontaneously contracting chick embryo ventricular cells were prepared as previously described (8) . Briefly, fragments of embryonic chick ventricles 10 Contractile response measurements. To determine the contractile response of cultured heart cells to (±)-BAYk 8644, measurements of the amplitude of contraction of individual cells in a spontaneously contracting monolayer at 3 d in culture were conducted with the phase-contrast microscope-video motion detector system previously described in detail (8) . The medium that superfused cells during contractility measurements was a Hepes-buffered solution containing (in millimeter): Hepes, 5.0; CaCl2, 0.9; KCI, 4.0; NaCl, 140; MgCl2, 0.5; and 2% FCS. Flow rate was 1 ml/min. After a 10-min equilibration period, cells were superfused with 0.1 M (±)-BAYk 8644. Previous experiments have demonstrated that this concentration produces the peak contractile response in this system (1 1). The amplitude of contraction was recorded and measured as described by Marsh et al. (8) . Previous studies from our own (9, 12 ) and other laboratories (13, 14) have demonstrated that changes in amplitude and velocity of cell motion can be used to quantify the effects of a variety of interventions on cell contractility.
Loading conditions for contraction caused by attachment of the cell to the coverslip and other cells, as well as the viscoelastic properties of each cell, may vary from cell to cell. However, by expressing the contractile response of the cell as a percentage of its maximal or basal response, these differences in loading conditions are taken into account and each cell can serve as its own control ( 12 (10) . Equilibrium binding isotherms were uniformly monophasic (saturable) and were best described by a single-af-finity state for CGP 12177 (Fig. 1) To determine whether regulation of DHP binding sites requires ,3-adrenergic receptor occupancy or whether elevation of intracellular cAMP by nonreceptor mediated mechanisms is sufficient to produce DHP receptor regulation, intact cultured cells were exposed to 1 x 10-4 M isobutylmethylxanthine (IBMX) and forskolin (20 MM). This produced an increase in total cellular cAMP from 0.21±0.04 to 6.0±0.3 nmol/mg protein (P < 0.01, n = 4). Cells incubated with IBMX and forskolin for 4 h and paired control plates of cells then had DHP binding sites determined by PN200-1 10 binding. Kd for PN200-110 was not significantly changed by drug 4"Ca uptake. To determine whether a decrease in DHP binding sites might be associated with altered calcium uptake kinetics in the cultured heart cells, the initial velocity of 45Ca uptake was determined in naive cultured heart cells and cells that had previously been exposed to 1 MM isoproterenol for 4 h. In this preparation, -30% of calcium uptake into a rapidly exchangeable pool is sensitive to calcium channel antagonists and is likely to be via L-type Ca channels (16) . Accordingly, Exposure of intact cultured myocardial cells to saturating concentrations of isoproterenol produced downregulation of cell surface ,3-adrenergic receptors, as would be expected from previous studies from this and other laboratories (10, 12, 21, 22) . A significant new finding of this study is that when DHP binding sites are assayed in intact cells after a 4-h incubation with isoproterenol, there is a decrease in the number of DHP binding sites to 65% ofcontrol with no change in the affinity of the remaining DHP binding sites for the antagonist ligand. Moreover, when cAMP content is elevated by a non-receptor-mediated mechanism (stimulation of the catalytic subunit of adenylate cyclase with forskolin and inhibition of phosphodiesterase by IBMX), there is a very similar reduction in number of PN200-1 10 binding sites with no change in affinity for the ligand. These results are summarized in Fig. 3 .
Radioligand binding to DHP binding sites is currently the best available method for pharmacologically determining the number ofcalcium channels on or within an intact cell. Nevertheless, there are limitations to this approach (see below). To determine whether the change in the number of DHP binding sites, which is used as a surrogate for determination of the number of copies of the calcium channel proteins in the cell membrane has physiological importance, an index of calcium channel function was measured in control cells and cells with downregulated calcium channels under conditions identical to those for the binding studies. BAY k 8644 augmentation of 45Ca uptake was used as an index of abundance of functional or recruitable calcium channels. Because only a fraction of calcium uptake in this model system is via the voltage-dependent calcium channel (-25-30%, reference 16), a larger signal to noise ratio could be achieved by using conditions that stimulate calcium channel-dependent flux rather than just measuring basal uptake. BAYk 8644 produced a small but highly reproducible increase in 45Ca uptake velocity at 60 s in naive cells. The 45Ca uptake velocity was substantially less after the cells had been exposed to isoproterenol for 4 h. Control experiments demonstrated that the decrease in BAYk 8644-stimulated 45Ca uptake velocity could not be attributed to calcium overload of the cell.
To bolster further the evidence that (l-adrenergic agonistinduced downregulation of the calcium channel had physiological significance, calcium channel agonist-induced increase in amplitude of contraction of the intact cells was studied under conditions identical to those of ,B-adrenergic receptor binding studies, calcium channel ligand binding, and 45Ca uptake studies. Again, cells exposed to isoproterenol for 4 h had a smaller response to a calcium channel agonist than naive cells (Fig. 3) . Moreover, under conditions where the number of DHP binding sites is decreased, and the contractile response to a calcium channel agonist is decreased, the portion of 4'Ca uptake sensitive to verapamil tended to decrease (25 vs. 5%).
Together, this series of experiments demonstrates that when (6) . In a similar skeletal muscle myotube system, activation of protein kinase C has been reported to modulate DHP receptors (26) and in a smooth muscle cell line, differentiation, mitogens, and oncogenes can regulate the expression of voltage-gated calcium channels (27) . Thus (7) . One might postulate that sustained phosphorylation ofthe calcium channel may lead to its internalization. The most likely mechanism is prolonged activation of cAMP-dependent protein kinase (5) . For another sarcolemmal structure, the ,3-adrenergic receptor, sustained phosphorylation by cAMP-dependent kinase and ,B receptor kinase has been demonstrated to uncouple the ,B receptor and promote its translocation into the cytosol (29) (30) (31) . To confirm this hypothesis, it will be necessary to demonstrate sustained phosphorylation of cardiac calcium channels that are translocated out ofthe sarcolemma.
There are several areas of agreement regarding regulation of the abundance and function of cardiac calcium channels.
First, it is evident that calcium channel gating properties are modulated by phosphorylation of the channel by cAMP-dependent protein kinase (5) . Second, the data presented here demonstrate that elevation of cAMP in intact myocardial cells for 4 h produces a decrease in abundance ofDHP binding sites and a decrease in indices of calcium channel function. Third, there is now evidence that G, can directly modulate calcium channel function by a mechanism independent of cAMP-dependent protein kinase (32) . It has also been established that over the course of days, in a process requiring protein synthesis, excess thyroid hormone can lead to increase in expression of DHP binding sites and calcium channel-dependent calcium flux (25) . Unresolved 
